Drug Type Small molecule drug |
Synonyms Cytolytic thioxanthone, Thioxanthone, BCN 326862 + [5] |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H27N3O3S |
InChIKeyGWLFIMOOGVXSMZ-UHFFFAOYSA-N |
CAS Registry155990-20-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Phase 1 | FR | - | |
Leukemia | Phase 1 | - | - | |
Lymphoma | Phase 1 | FR | - | |
Lymphoma | Phase 1 | - | - | |
Solid tumor | Phase 1 | - | - |
ASCO2005 Manual | Phase 1 | 31 | caplcmikph(tmptkarawz) = mucbqhcxev mkoipijapm (jstmpotidx ) | Not Applicable | 01 Jun 2005 | ||
Phase 1 | 17 | yfgvzagegj(ckmmaycipv) = zhwtfctxlz jvifnvxdwr (uzxmjwvrpn ) | - | 01 Jun 2005 | |||
Phase 1 | 18 | ybspwufrta(itrtpztvbo) = mdflwcayyn xpuphsffuz (tzlggyimvk ) | - | 01 Jun 2005 |